Photodynamic therapy (PDT) has been extensively explored
as a noninvasive
cancer treatment modality. However, the dilemma of tumor hypoxia and
short half-life of singlet oxygen (1O2) severely
restrict the therapeutic efficacy of PDT. Herein, we develop a facile
three-in-one PDT nanoamplifier (AA@PPa/Hemin NPs) assembled by pyropheophorbide
a (PPa), hemin, and arachidonic acid (AA). Interestingly, AA not only
acts as an enabler to facilitate the assembly of PPa and hemin in
the construction of ternary hybrid nanoassemblies but also acts as
a lipid reactive oxygen species (ROS) amplifier for robust PDT. In
tumor cells, hemin plays the role of a catalase-like catalyst that
accelerates the production of oxygen (O2) from hydrogen
peroxide (H2O2), significantly alleviating tumor
hypoxia. Under laser irradiation, vast amounts of 1O2 generated by PPa trigger the peroxidation of AA to produce
large amounts of cytotoxic lipid ROS, immensely amplifying the efficiency
of PDT by promptly eliciting cellular oxidative stress. As expected,
AA@PPa/Hemin NPs exert potent antitumor activity in a 4T1 breast-tumor-bearing
BALB/c mice xenograft model. Such a cascade nanohybrid amplifier provides
a novel codelivery platform for accurate and effective PDT of cancer.